Your browser doesn't support javascript.
loading
Factors associated with malaria vaccine uptake in Nsanje district, Malawi.
Simbeye, Atusaye J; Kumwenda, Save; Cohee, Lauren M; Omondi, Dickens; Masibo, Peninah K; Wao, Hesborn; Awandu, Shehu S.
Afiliação
  • Simbeye AJ; Department of Biomedical Sciences, School of Health Sciences, Jaramogi Oginga Odinga University of Science and Technology, P. O. Box 210-40601, Bondo, Kenya. atusayesimbeye@gmail.com.
  • Kumwenda S; Department of Public and Environmental Health Sciences, School of Science and Technology, Malawi University of Business and Applied Sciences, Chichiri, Private Bag 303, Blantyre, Malawi.
  • Cohee LM; Department of Pediatrics, Division of Infectious Disease and Tropical Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 655 B Baltimore St S, Baltimore, MD, 21201, USA.
  • Omondi D; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
  • Masibo PK; Department of Biomedical Sciences, School of Health Sciences, Jaramogi Oginga Odinga University of Science and Technology, P. O. Box 210-40601, Bondo, Kenya.
  • Wao H; School of Public Health, Amref International University, P. O. Box 27691-00506, Nairobi, Kenya.
  • Awandu SS; African Population and Health Research Centre (APHRC), P. O. Box 10787-00100, Nairobi, Kenya.
Malar J ; 23(1): 105, 2024 Apr 17.
Article em En | MEDLINE | ID: mdl-38627704
ABSTRACT

BACKGROUND:

Malaria remains a significant global health burden affecting millions of people, children under 5 years and pregnant women being most vulnerable. In 2019, the World Health Organization (WHO) endorsed the introduction of RTS,S/AS01 malaria vaccine as Phase IV implementation evaluation in three countries Malawi, Kenya and Ghana. Acceptability and factors influencing vaccination coverage in implementing areas is relatively unknown. In Malawi, only 60% of children were fully immunized with malaria vaccine in Nsanje district in 2021, which is below 80% WHO target. This study aimed at exploring factors influencing uptake of malaria vaccine and identify approaches to increase vaccination.

METHODS:

In a cross-sectional study conducted in April-May, 2023, 410 mothers/caregivers with children aged 24-36 months were selected by stratified random sampling and interviewed using a structured questionnaire. Vaccination data was collected from health passports, for those without health passports, data was collected using recall history. Regression analyses were used to test association between independent variables and full uptake of malaria vaccine.

RESULTS:

Uptake of malaria vaccine was 90.5% for dose 1, but reduced to 87.6%, 69.5% and 41.2% for dose 2, 3, and 4 respectively. Children of caregivers with secondary or upper education and those who attended antenatal clinic four times or more had increased odds of full uptake of malaria vaccine [OR 2.43, 95%CI 1.08-6.51 and OR 1.89, 95%CI 1.18-3.02], respectively. Children who ever suffered side-effects following immunization and those who travelled long distances to reach the vaccination centre had reduced odds of full uptake of malaria vaccine [OR 0.35, 95%CI 0.06-0.25 and OR 0.30, 95%CI 0.03-0.39] respectively. Only 17% (n = 65) of mothers/caregivers knew the correct schedule for vaccination and 38.5% (n = 158) knew the correct number of doses a child was to receive.

CONCLUSION:

Only RTS,S dose 1 and 2 uptake met WHO coverage targets. Mothers/caregivers had low level of information regarding malaria vaccine, especially on numbers of doses to be received and dosing schedule. The primary modifiable factor influencing vaccine uptake was mother/caregiver knowledge about the vaccine. Thus, to increase the uptake Nsanje District Health Directorate should strengthen communities' education about malaria vaccine. Programmes to strengthen mother/caregiver knowledge should be included in scale-up of the vaccine in Malawi and across sub-Saharan Africa.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Antimaláricas / Malária Limite: Child / Child, preschool / Female / Humans / Infant / Pregnancy País/Região como assunto: Africa Idioma: En Revista: Malar J Assunto da revista: MEDICINA TROPICAL Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Quênia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Antimaláricas / Malária Limite: Child / Child, preschool / Female / Humans / Infant / Pregnancy País/Região como assunto: Africa Idioma: En Revista: Malar J Assunto da revista: MEDICINA TROPICAL Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Quênia